Date: September 20th, 2023

Time: 3:30pm ET

Attendees (9)

Name 

Affiliation

Role

Attended?

Randi Kudner

ASTRO

Champion / Primary Point of Contact


Samantha Dawes

ASTRO

Champion


Charlotte RaleyASTROASTRO measures and RT SupportX

Stephanie Jones

ASCO

Champion / Primary Point of Contact


Caitlin Drumheller

ASCO

ASCO Measure SME

X

Yvette Apura

ASCO

Clinical Informaticist / ASCO Measure SME


Becky Metzger

Telligen

Champion / Primary Point of Contact

X

Gail Winters

Telligen

Technical SME

X

Sharon Labbate

Telligen

Technical / Terminology SME

X

Jessica PughTelligenProject Management for Telligen-focused tasksX

Dennis Blair

Evernorth

Champion / Primary Point of Contact


Rick Emery

Evernorth

Champion


Dr. Mary Kay Barton

Evernorth

Medical Oncology SME


Dr. Vik Shah

Evernorth

Medical Oncology SME / Cigna Representative


Dr. Nimi Tuamokumo

Evernorth

Radiation Oncology SME


Sondra Berger

Evernorth

Business Development


Sharon Sebastian

MITRE

Clinical Informaticist / Terminology Support

X

Rob Dingwell

MITRE

Technical Support


Liz Canzone, Ph.D.  

MITRE

Director of Operations of CodeX


Anthony DiDonato

MITRE

Project Co-Coordinator

X

Doug Williams

CentanniPark

Project Co-Coordinator

X

Action items

  •  Anthony → schedule call with Anthony, Gail, Caitlin sometime next week to discuss poster presentation for the ASCO conference.

Planned Agenda Topics

  1. Review action items from 9/6 and 9/13 meetings:
    1. 9/6 - Stephanie - Upcoming Call - September 29th reach out to clinicians to help create added narratives
    2. 9/6 - Stephanie - Reach out to McKesson - FHIR/mCode implementation - and narratives (immediate)
    3. 9/6 - Gail W. and Sharon L. -  Clean up documentation for initial narratives - build a few more - post to Confluence
    4. 9/13 - Anthony - Transfer Quality Measures Public Call Outreach to CodeX outreach (so single source o truth) - indicate public call
  2. Meeting cadence
    1. QM Terminology meeting every 2 weeks?
  3. Engagement Updates:
    1. PQA - from Lisa Hines: "may be premature for PQA to engage with CodeX on quality measure work at this point in time. However, we appreciate the updates." 
    2. PQA published a report, Recommendations to Improve the Quality of Oral Anticancer Medication Use. Here is a related blog.
  4. Telligen to share template of CDR test scenario(s) - use this call to get a head start and then review materials in October call.
    1. Also start with sharing info via email. Sharon to lead walk-through of CDR template (1 scenario example)


Discussion Notes

Agenda Item #1

  • No updates

Agenda item #2

  • Becky asked to keep terminology meetings once per month at this point in time.

Agenda item #3

  • PQA will not be joining CodeX / QM use case at this time

Agenda item #4

Lung cancer test patient example was reviewed during today’s call.

Next Steps: 

  • QM team to review narrative specs of the test patients (3-5 breast, 3-5 lung, 1 for colon, 1 for blood cancer, etc.) to cover 80% of the anticipated data that would be collected for the quality measures.
  • Behind the scenes, Telligen will be translating the narrative spec to JSON bundles. The mapping of clinical concepts within the test patient cases to mCODE profiles, etc. is this first step.








  • No labels